| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology
|
de Vries, Paul S.
|
|
|
133 |
9 |
p. 967-977
|
artikel
|
| 2 |
A new Burkitt “look-alike” lymphoma
|
Cairo, Mitchell S.
|
|
|
133 |
9 |
p. 889-891
|
artikel
|
| 3 |
A topological view of human CD34+ cell state trajectories from integrated single-cell output and proteomic data
|
Knapp, David J.H.F.
|
|
|
133 |
9 |
p. 927-939
|
artikel
|
| 4 |
Bad weed: synthetic cannabinoid–associated coagulopathy
|
Arepally, Gowthami M.
|
|
|
133 |
9 |
p. 902-905
|
artikel
|
| 5 |
Bruton tyrosine kinase degradation as a therapeutic strategy for cancer
|
Dobrovolsky, Dennis
|
|
|
133 |
9 |
p. 952-961
|
artikel
|
| 6 |
CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma
|
Martín-Garcia, David
|
|
|
133 |
9 |
p. 940-951
|
artikel
|
| 7 |
Cold agglutinins: fending off the attack
|
Berentsen, Sigbjørn
|
|
|
133 |
9 |
p. 885-886
|
artikel
|
| 8 |
Development of a virtual benign hematology consultation service: results of a pilot project involving 5 medical centers
|
Pai, Ashok
|
|
|
133 |
9 |
p. 993-995
|
artikel
|
| 9 |
Durable remissions with obinutuzumab-based chemoimmunotherapy: long-term follow-up of the phase 1b GALTON trial in CLL
|
Brown, Jennifer R.
|
|
|
133 |
9 |
p. 990-992
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
133 |
9 |
p. i
|
artikel
|
| 11 |
Fibronectin: a “double hit” modulator in HIT?
|
Gruel, Yves
|
|
|
133 |
9 |
p. 891-892
|
artikel
|
| 12 |
Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT
|
Krauel, Krystin
|
|
|
133 |
9 |
p. 978-989
|
artikel
|
| 13 |
Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial
|
Jäger, Ulrich
|
|
|
133 |
9 |
p. 893-901
|
artikel
|
| 14 |
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL
|
Klanova, Magdalena
|
|
|
133 |
9 |
p. 919-926
|
artikel
|
| 15 |
Low-dose rituximab in autoimmune hemolytic anemia: 10 years after
|
Fattizzo, Bruno
|
|
|
133 |
9 |
p. 996-998
|
artikel
|
| 16 |
Refining CNS relapse risk in DLBCL: easy as ABC?
|
Fox, Christopher P.
|
|
|
133 |
9 |
p. 886-888
|
artikel
|
| 17 |
Severe mosquito bite allergy: an unusual EBV+ NK cell lymphoproliferative disorder
|
Said, Jonathan
|
|
|
133 |
9 |
p. 999
|
artikel
|
| 18 |
The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma
|
Wagener, Rabea
|
|
|
133 |
9 |
p. 962-966
|
artikel
|
| 19 |
Three targets in 1 shot against ibrutinib resistance
|
Chiron, David
|
|
|
133 |
9 |
p. 888-889
|
artikel
|
| 20 |
Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms
|
Jackson, Shaun P.
|
|
|
133 |
9 |
p. 906-918
|
artikel
|
| 21 |
Transient appearance of ring sideroblasts in peripheral blood in the acute phase of secondary hemolytic anemia
|
Wang, Fei
|
|
|
133 |
9 |
p. 1000
|
artikel
|
Tijdschrift beschrijving